Seattle-area psychedelics startup CaaMTech raises $22M to advance to human testing
CaaMTech aims to take the uncertainty out of psychedelics like magic mushrooms and to provide defined formulations. (BigStock photo) CaaMTech, a Seattle-area startup developing new psychedelic agents, has raised $ 22 million in funding, the company announced this week. The company synthesizes a number of new compounds that are similar to those found in “magic … Read more